$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Introduction to the domestic launch time and market supply situation of Bikken Pronol Tablets (Bituvi)
2026-02-01 22:25:32
Check Details
Deuterated colexitinib (decavatinib) approved indications and latest guidelines
2026-02-01 22:25:32
Check Details
What specific symptoms can Apremilast (Otelor) improve in patients with psoriasis?
2026-02-01 22:25:32
Check Details
Once you start taking Valganciclovir, do you need to take it for a long time?
2026-02-01 22:25:32
Check Details
Research on the potential application of osimertinib (Tagrisso) in the treatment of breast cancer
2026-02-01 22:25:32
Check Details
Differences and usage comparison between avatrombopag and eltrombopag (Revlan)
2026-02-01 22:25:32
Check Details
Roprostim (Huierning) complete Chinese instructions and medication guidance
2026-02-01 22:25:32
Check Details
How long does it take for the adverse reactions of Midostaurin to resolve or disappear on their own?
2026-02-01 22:25:32
Check Details
Does cabergoline cause allergic reactions and how to deal with them
2026-02-01 22:25:32
Check Details
Summary of clinical efficacy and patient feedback of momelotinib
2026-02-01 22:25:32
Check Details
Is Bikeren Prenol Tablets (Bituvi) a blocking drug and analysis of its mechanism of action
2026-02-01 22:25:32
Check Details
What is Voyxact (sibeprenlimab-szsi) a medicine for?
2026-02-01 22:25:32
Check Details
1
2
...
2345
2346
2347
2348
2349
2350
2351
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
2
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
3
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
4
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
5
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
6
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
7
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
8
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
9
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
10
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
11
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
12
Trelagliptin: A Once-Weekly Long-Acting Oral DPP-4 Inhibitor